Pharmaco - Press Releases

Date	Title	Company
04-Apr-2023	iOmx Therapeutics Announces Dosing of First Patient with SIK Inhibitor OMX-0407 in Phase I Clinical Trial	iOmx Therapeutics AG
04-Apr-2023	QUANTRO Therapeutics appoints Industry Expert Dr. Michael Bauer as Chief Executive Officer	QUANTRO Therapeutics GmbH
04-Apr-2023	Mainz Biomed Expands Corporate Health Program for ColoAlert with the Addition of Three New Companies in Germany	Mainz BioMed N.V.
04-Apr-2023	Relief Therapeutics Holding SA to Hold Extraordinary General Meeting of Shareholders	Relief Therapeutics Holding SA
03-Apr-2023	PAION receives European Commission approval of remimazolam for the Induction and maintenance of general anesthesia in adults	PAION AG
03-Apr-2023	EBViously Announces First Details of Its EBV-001 Vaccine Candidate for the Prevention of Epstein-Barr Virus (EBV)-Induced Diseases	EBViously
03-Apr-2023	aap Implants Inc. awarded agreement with Premier, Inc. for Small Joint Implants – Upper Extremities, Small Joint Implants – Lower Extremities, Podiatry Products and Accessories	aap Implantate AG
03-Apr-2023	Relief Therapeutics Appoints World-Renowned Gene Therapy Pioneer Guangping Gao, Ph.D. as Chair of Scientific Advisory Board	Relief Therapeutics Holding SA
03-Apr-2023	PolyPeptide appoints Juan-José Gonzalez as CEO and announces change of CFO	PolyPeptide Group
31-Mar-2023	Rxilient Biotech and Junshi Biosciences form Joint Venture to develop and commercialize Toripalimab in Southeast Asia	Rxilient Biotech
31-Mar-2023	PAION AG implements resolved capital reduction	PAION AG
31-Mar-2023	MediClin AG: Group sales and Group operating result above previous year − cautious outlook for 2023	MediClin AG
31-Mar-2023	Almirall: The New England Journal of Medicine (NEJM) and the British Journal of Dermatology (BJD) publish Ph3 data evaluating lebrikizumab efficacy and safety in moderate-to-severe atopic dermatitis	Almirall
31-Mar-2023	Call for urgency to deliver on global pledge for antibiotic incentives	ABPI
31-Mar-2023	Sartorius Stedim Biotech SA: Sartorius Stedim Biotech to acquire Polyplus	Sartorius Stedim Biotech SA
31-Mar-2023	Lonza Launches Share Buyback Program of up to CHF 2 Billion	Lonza Group AG
31-Mar-2023	AEVIS VICTORIA SA – Publication of the Annual Report 2022	AEVIS VICTORIA SA
31-Mar-2023	Modern Dental Group Announces 2022 Annual Results - Recorded the Second Highest Net Profit of HK$221 million and Built a Comprehensive Dental Ecosystem with High-quality Development	Modern Dental Group Limited
30-Mar-2023	Biophytis: The Combined General Meeting will be held on second call on April 17, 2023	Biophytis
30-Mar-2023	Clinical Study of TISSIUM’s COAPTIUM Connect Atraumatic Sutureless Nerve Coaptation System Is Underway in Australia	TISSIUM